Literature DB >> 8102114

Dopamine D2 receptor RFLPs, haplotypes and their association with substance use in black and Caucasian research volunteers.

B F O'Hara1, S S Smith, G Bird, A M Persico, B K Suarez, G R Cutting, G R Uhl.   

Abstract

Alleles of the dopamine D2 receptor gene are distinguished by polymorphic A and B TaqI sites approximately 10 kb 3' to the final exon and bordering the second exon, respectively. These alleles have been reported to be more prevalent in heavy substance users than in control populations in several, although not all studies. Meta-analyses of combined data from available work support significant association. Two competing hypotheses could explain this association: (1) the A1 and B1 RFLPs are in linkage disequilibrium with a functional allelic determinant that in some way influences behavior; (2) the affected subjects are drawn disproportionately from populations stratified on the basis of, for example, ethnicity that happen to have higher A1 and B1 RFLP frequencies. We report here data collected from 616 substance-abusing and control individuals that document substantial differences in A1 RFLP frequencies between white and black Americans, the almost exclusive presence of the A3 RFLP in blacks, and low frequencies of rare A4 and B3 RFLPs. In blacks, neither the A1 nor B1 RFLPs display association with substance use, while white individuals display significant association with polysubstance use. When expressed as a percent of the maximum possible disequilibrium, both white and black individuals display strong linkage disequilibrium between these loci, although blacks display many more A1/B2 chromosomes. These racial differences in TaqI RFLP haplotypes underscore the need for caution in interpreting allelic associations when careful matching for ethnicity has not been performed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102114     DOI: 10.1159/000154133

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  21 in total

1.  Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics.

Authors:  Terry Ritchie; Ernest P Noble
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

2.  A search for association between schizophrenia and dopamine-related alleles.

Authors:  E Jönsson; S Brené; T Geijer; L Terenius; A Tylec; M L Persson; G Sedvall
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

Review 3.  A review of pharmacogenetic studies of substance-related disorders.

Authors:  Jermaine D Jones; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2015-03-18       Impact factor: 4.492

4.  Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status.

Authors:  Sarah A Eisenstein; Ryan Bogdan; Latisha Love-Gregory; Nadia S Corral-Frías; Jonathan M Koller; Kevin J Black; Stephen M Moerlein; Joel S Perlmutter; Deanna M Barch; Tamara Hershey
Journal:  Synapse       Date:  2016-06-17       Impact factor: 2.562

5.  Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.

Authors:  Kenneth Blum; Marlene Oscar-Berman; Rajendra D Badgaiyan; Tomas Palomo; Mark S Gold
Journal:  Med Hypotheses       Date:  2014-02-26       Impact factor: 1.538

6.  Heroin delay discounting and impulsivity: Modulation by DRD1 genetic variation.

Authors:  Tabitha E H Moses; Margit Burmeister; Mark K Greenwald
Journal:  Addict Biol       Date:  2019-06-13       Impact factor: 4.280

7.  The dopamine D2 receptor mediates approach-avoidance tendencies in smokers.

Authors:  Armin Zlomuzica; Alla Machulska; Susanna Roberts; Michael von Glischinski; Mike Rinck; Kathryn J Lester; Thalia C Eley; Jürgen Margraf
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-31       Impact factor: 5.270

8.  Reduced visuospatial performance in children with the D2 dopamine receptor A1 allele.

Authors:  S M Berman; E P Noble
Journal:  Behav Genet       Date:  1995-01       Impact factor: 2.805

Review 9.  Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).

Authors:  Kenneth Blum; Thomas J H Chen; B William Downs; Abdalla Bowirrat; Roger L Waite; Eric R Braverman; Margaret Madigan; Marlene Oscar-Berman; Nicholas DiNubile; Eric Stice; John Giordano; Siobhan Morse; Mark Gold
Journal:  Postgrad Med       Date:  2009-11       Impact factor: 3.840

10.  Impulse activity of midbrain dopamine neurons modulates drug-seeking behavior.

Authors:  Michela Marinelli; Donald C Cooper; Lorinda K Baker; Francis J White
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.